Thursday, March 30, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from Siemens Healthineers.
Rapid Fire
Noninvasive tests for fibrosis in NAFLD
Available
Available
Available
Steering Committee Co-Chair
President
Inova Medicine Services Professor and Chairman
Department of Medicine
Inova Fairfax Medical Campus
Fairfax, Virginia, United States
Steering Committee Co-Chair
Interim-Chair
Division of Gastroenterology, Hepatology and Nutrition
Professor of Medicine, Physiology and Molecular Pathology
VCU/VCUHealth
Chair
NIH NASH Clinical Research Network
Richmond, Virginia, United States
Steering Committee Member
Professor of Medicine
Angers University
Angers University Hospital
Angers, France
Steering Committee Member
Professor of Medicine
UChicago Medicine
Chicago, Illinois, United States
Steering Committee Member
Adjunct Assistant Professor of Medicine
Emory University School of Medicine
Atlanta, Georgia, United States
Steering Committee Member
Professor of Medicine
Director
Metabolic Liver Research Program
Department of Medicine
University Medical Center Mainz
Mainz, Germany
Steering Committee Chair
Has disclosed has no relevant financial relationships.
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Consultant or advisor for: 89 Bio; Albireo; Alnylam; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; Covance; Genentech; Genfit; Gilead; HemoShear; HistoIndex; Intercept; Inventiva; Janssen; Lilly; Madrigal; Mallinckrodt; Merck; NGM Bio; Novartis; Novo Nordisk; PathAI; Pfizer; Poxel; ProSciento; Regneron; Roche; Salix; Siemens; Terns
Research funding from: Boehringer Ingelheim; Bristol Myers Squibb; Echosens-Sandhill; Fractyl; Gilead; Inventiva; Lilly; Madrigal; Mallinckrodt; Merck; Novartis; Novo Nordisk; Siemens
Stock options from: Durect; Exhalenz; Genfit; Indalo; NorthSea; RivusSequana; Tiziana
Has disclosed the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Bristol Myers Squibb Company; Echosens; Intercept; Merck Sharp & Dohme; Novo Nordisk; Pfizer
Speaker or member of speakers bureau for: AbbVie; Gilead; Intercept; Siemens
Research funding from: Diafir; Echosens; Intercept; Inventiva; Siemens
Patent beneficiary of: Echosens (FibroMeterVCTE)
Has disclosed no relevant financial relationships.
Has disclosed no relevant financial relationships.
Has disclosed the following relevant financial relationships:
Consultant or advisor for: Albireo Pharma Inc; Apollo Endosurgery; Bayer; Boehringer Ingelheim; Bristol Myers Squibb; Gilead Sciences; GlaxoSmithKline; Intercept Pharmaceuticals; Inventiva Pharma; Ipsen; Madrigal; Merck Sharp & Dohme; Northsea Therapeutics; Novartis; Novo Nordisk; Pfizer; Roche; Sanofi; Siemens Healthcare GmbH
Speaker or member of speakers bureau for: Boehringer Ingelheim; Echosens; Madrigal Pharmaceuticals; MedPublico GmbH; Novo Nordisk
Research funding from: Boehringer Ingelheim; Gilead Sciences; Siemens Healthcare GmbH